GRNH - GreenGro Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.0014 (-5.82%)
At close: 3:55PM EST
Stock chart is not supported by your current browser
Previous Close0.0239
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0200 - 0.0260
52 Week Range0.0163 - 0.0950
Avg. Volume3,087,285
Market Cap9.903M
Beta (3Y Monthly)-0.63
PE Ratio (TTM)0.01
EPS (TTM)1.9180
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire15 hours ago

    GreenGro Technologies Plans To File for Name Change And Expands Its Services Direct Into The State Licensed Cannabis Markets

    GreenGro Technologies (GRNH), a well-respected provider of eco-friendly green technologies, today announced that it has begun the process to change the company name. Upon completion of the application process, the company will be known as GreenGro Holdings, Inc. “We have already reserved the new name and look forward to stepping into the scope of goods and services we have been planning to provide,” said GreenGro Chairman and CEO, James Haas.

  • GlobeNewswire6 days ago

    Gala Pharmaceutical Files State License Application for Testing Facility

    Gala Pharmaceutical, Inc. (GLPH), a robust and burgeoning Analytical testing company, today announced notable progress toward opening its doors and serving its rapidly growing market. The Company’s application to operate a TYPE 8 Medical Cannabis Testing Lab has been deemed complete by the City of Long Beach and, through its subsidiary, Gala Pharmaceutical California, Inc., has filed for its California state license. In addition, Gala has submitted the application for its building permit.

  • GlobeNewswire14 days ago

    GreenGro Technologies Strengthens Board of Directors

    ANAHEIM, Calif., Nov. 29, 2018 -- GreenGro Technologies, Inc. (OTC: GRNH), a world-class provider of eco-friendly green technologies, today announced the appointment of.

  • GlobeNewswire2 months ago

    GreenGro Technologies Announces Launch of CBD Division

    GreenGro Technologies, Inc. (GRNH), a world-class provider of eco-friendly green technologies, today announced the launch of its newly formed CBD Subsidiary, EMS Meds, Inc., which will focus on the research and development of a full line of premium CBD products that will be distributed directly to doctors’ offices, medical facilities and specialty retailers. EMS Meds will serve as the GreenGro’s clinical arm dedicated to the production of CBD-based medicines and treatments.  GreenGro noted that its targeted distribution network, which should be covered by most insurance carriers, will make its CBD products available to a large number of patients who until today could not afford CBD-derived medications.

  • GlobeNewswire2 months ago

    Leading Investment Newsletter Ranks GreenGro Technologies as 10th Most Attractive Stock to Own Out of List of 30 Other Cannabis Securities

    ANAHEIM, Calif., Oct. 03, 2018 -- GreenGro Technologies, Inc. (OTC: GRNH), an established provider of eco-friendly green technologies, today announced that a leading.

  • GlobeNewswire3 months ago

    UPDATE: Gala Pharmaceutical to Form Strategic Alliances to Boost Demand for Cannabis Testing Facilities

    Gala Pharmaceutical, Inc. (GLPH), an emerging cannabis testing company, today announced it expects to form strategic alliances with GreenGro Technologies (GRNH), a developer of eco-friendly greenhouses, and igot420distribution, a network of distribution centers connecting farms and manufacturing labs to licensed medical and recreational dispensaries, to boost initial demand for Gala Pharmaceutical’s cannabis testing facilities.  Under the terms of the agreements, over the next several months, the three companies will collaborate to develop a joint sales, marketing and distribution strategy that will collectively take them one step closer towards becoming a true vertically integrated solution provider for the cannabis industry. “Our partnerships with GreenGro Technologies and igot420 distribution will enable Gala Pharmaceutical to further develop and leverage our marketing and sales efforts to strengthen our position in the emerging market for cannabis testing facilities,” said Dr. Rehman, Chief Executive Officer of Gala Pharmaceutical, Inc. “These alliances will allow us to gain access to their deep-rooted and extensive client relationships across the cannabis industry, which will rapidly boost demand for our cannabis testing facilities as the state continues to phase in new cannabis testing regulations throughout the year,” concluded Dr. Rehman.